INSTITUTO ROSENBUSCH S.A. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.4 ARS | -3.58% |
|
-8.85% | +30.31% |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 268.3 | 238.5 | 489.8 | 468.5 | 549.4 | 2,726 |
| Enterprise Value (EV) 1 | 347.2 | 387.3 | 597 | 602.5 | 787.7 | 3,369 |
| P/E ratio | 336 x | -1.96 x | -28.8 x | -23.9 x | -67.8 x | 4.84 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.9 x | 0.43 x | 0.88 x | 0.6 x | 0.4 x | 0.6 x |
| EV / Revenue | 1.16 x | 0.69 x | 1.07 x | 0.77 x | 0.57 x | 0.74 x |
| EV / EBITDA | 8.3 x | -15.2 x | 7.27 x | 13.5 x | 2.48 x | 27.5 x |
| EV / FCF | 34.1 x | -12.5 x | 7.75 x | -15.3 x | 5.1 x | -3.01 x |
| FCF Yield | 2.94% | -7.97% | 12.9% | -6.52% | 19.6% | -33.2% |
| Price to Book | 2.1 x | 1.67 x | 3.76 x | 2.65 x | 1.51 x | 1.42 x |
| Nbr of stocks (in thousands) | 42,589 | 42,589 | 42,589 | 42,589 | 42,589 | 42,589 |
| Reference price 2 | 6.300 | 5.600 | 11.50 | 11.00 | 12.90 | 64.00 |
| Announcement Date | 3/15/19 | 4/5/21 | 4/5/21 | 3/13/22 | 3/20/23 | 3/27/24 |
1ARS in Million2ARS
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 298.9 | 560.7 | 558.6 | 781.6 | 1,373 | 4,528 |
| EBITDA 1 | 41.85 | -25.49 | 82.12 | 44.7 | 317.2 | 122.7 |
| EBIT 1 | 36.64 | -44.51 | 63.65 | 21.55 | 267.2 | 15.78 |
| Operating Margin | 12.26% | -7.94% | 11.39% | 2.76% | 19.46% | 0.35% |
| Earnings before Tax (EBT) 1 | 20.7 | -110.7 | 5.027 | -19.57 | 10.48 | 629.8 |
| Net income 1 | 0.7983 | -121.4 | -17.01 | -19.57 | -8.098 | 562.9 |
| Net margin | 0.27% | -21.66% | -3.04% | -2.5% | -0.59% | 12.43% |
| EPS 2 | 0.0187 | -2.851 | -0.3993 | -0.4595 | -0.1901 | 13.22 |
| Free Cash Flow 1 | 10.2 | -30.87 | 77.06 | -39.3 | 154.6 | -1,117 |
| FCF margin | 3.41% | -5.51% | 13.79% | -5.03% | 11.26% | -24.68% |
| FCF Conversion (EBITDA) | 24.36% | - | 93.83% | - | 48.73% | - |
| FCF Conversion (Net income) | 1,277.23% | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/15/19 | 4/5/21 | 4/5/21 | 3/13/22 | 3/20/23 | 3/27/24 |
1ARS in Million2ARS
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 78.9 | 149 | 107 | 134 | 238 | 643 |
| Net Cash position 1 | - | - | - | - | - | - |
| Leverage (Debt/EBITDA) | 1.886 x | -5.838 x | 1.306 x | 2.998 x | 0.7513 x | 5.242 x |
| Free Cash Flow 1 | 10.2 | -30.9 | 77.1 | -39.3 | 155 | -1,117 |
| ROE (net income / shareholders' equity) | 6.1% | -75.9% | -9.2% | -11.3% | -3.44% | 34.1% |
| ROA (Net income/ Total Assets) | 6.25% | -5.33% | 5.88% | 1.52% | 11.9% | 0.21% |
| Assets 1 | 12.77 | 2,277 | -289 | -1,284 | -67.97 | 263,796 |
| Book Value Per Share 2 | 3.000 | 3.350 | 3.060 | 4.160 | 8.520 | 45.00 |
| Cash Flow per Share 2 | 0.3500 | 0.5000 | 1.120 | 1.340 | 2.500 | 9.180 |
| Capex 1 | 1.51 | 9.84 | 1.98 | 2.14 | 26.5 | 53 |
| Capex / Sales | 0.5% | 1.75% | 0.35% | 0.27% | 1.93% | 1.17% |
| Announcement Date | 3/15/19 | 4/5/21 | 4/5/21 | 3/13/22 | 3/20/23 | 3/27/24 |
1ARS in Million2ARS
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| +30.31% | 4.04M | |
| -15.35% | 76.23B | |
| -9.19% | 6.67B | |
| -0.56% | 3.21B | |
| +3.38% | 1.52B | |
| -15.13% | 1.37B | |
| -25.63% | 1.24B | |
| -7.13% | 1.21B | |
| -10.84% | 1.17B | |
| -.--% | 1.05B |
- Stock Market
- Equities
- ROSE Stock
- Financials Instituto Rosenbusch S.A.